Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Capital Employed (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Return on Capital Employed for 14 consecutive years, with 0.1% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 10.0% to 0.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.1% through Dec 2025, up 10.0% year-over-year, with the annual reading at 0.1% for FY2025, 10.0% up from the prior year.
  • Return on Capital Employed hit 0.1% in Q4 2025 for Ani Pharmaceuticals, up from 0.07% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.1% in Q4 2025 to a low of 0.09% in Q3 2022.
  • Historically, Return on Capital Employed has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
  • Biggest five-year swings in Return on Capital Employed: decreased -8bps in 2022 and later rose 15bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.07% in 2021, then increased by 27bps to 0.05% in 2022, then skyrocketed by 215bps to 0.06% in 2023, then plummeted by -99bps to 0.0% in 2024, then skyrocketed by 18015bps to 0.1% in 2025.
  • Business Quant data shows Return on Capital Employed for ANIP at 0.1% in Q4 2025, 0.07% in Q3 2025, and 0.01% in Q2 2025.